Researchers will explore a promising approach for treating degenerative diseases by replacing damaged cells with new ones and ...
Zenocutuzumab helps fill an important need for patients with advanced pancreatic cancer and NSCLC with NRG1 gene fusions, said Alison Schram M.D., ...
Stockhead on MSN10d
Phase III Trials: It’s crunch time for these ASX health stocksSeveral ASX-listed companies are undertaking phase III clinical trials, the critical final stage before potential regulatory ...
Prolonged exposure to microgravity in space weakens the heart muscle and disrupts the heart’s rhythm, Johns Hopkins ...
StudyFinds on MSN14d
Dogs with deadly cancer help scientists crack code of rare human diseaseScientists studying an aggressive cancer that affects thousands of dogs annually have uncovered a genetic signature that ...
We interview the winners of the L’Oréal-UNESCO For Women in Science Awards 2024, exploring their inspiring journeys ...
The Brighterside of News on MSN12d
Scientists discover why lungs are so prone to developing cancerLung metastases are a devastating reality for over half of cancer patients whose tumors spread beyond their initial sites.
According to a new market research report titled, 'Barcode Scanners Market by Offering (Product (Pen Type Readers, Laser ...
According to a new market research report titled, 'Barcode Scanners Market by Offering (Product (Pen Type Readers, Laser Barcode, Others), Consumables ...
In a trial, Gossamer Bio's PAH treatment candidate seralutinib reduced the resistance blood faces moving into the lungs over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback